{"id":"https://openalex.org/W4362540698","doi":"https://doi.org/10.1158/2326-6066.22544196.v1","title":"Supplementary Figure from Loss of LRRC33-Dependent TGF\u03b21 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy","display_name":"Supplementary Figure from Loss of LRRC33-Dependent TGF\u03b21 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362540698","doi":"https://doi.org/10.1158/2326-6066.22544196.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.22544196.v1","doi":"https://doi.org/10.1158/2326-6066.22544196.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22544196.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Loss_of_LRRC33-Dependent_TGF_1_Activation_Enhances_Antitumor_Immunity_and_Checkpoint_Blockade_Therapy/22544196/1/files/40007616.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Loss_of_LRRC33-Dependent_TGF_1_Activation_Enhances_Antitumor_Immunity_and_Checkpoint_Blockade_Therapy/22544196/1/files/40007616.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038007498","display_name":"Aiping Jiang","orcid":"https://orcid.org/0000-0002-8389-2950","observed_orcids":["https://orcid.org/0000-0002-8389-2950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aiping Jiang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8389-2950","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100510256","display_name":"Qin Yan","orcid":"https://orcid.org/0009-0001-7857-2653","observed_orcids":["https://orcid.org/0009-0001-7857-2653"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Qin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5003615852","display_name":"Timothy A. Springer","orcid":"https://orcid.org/0000-0001-6627-2904","observed_orcids":["https://orcid.org/0000-0001-6627-2904"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy A. Springer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6627-2904","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6586999893188477,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6586999893188477,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.3312999904155731,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.9829999804496765},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9490000009536743},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.8912308216094971},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.672144889831543},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.5935763716697693},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5333077311515808},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37620094418525696},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2659022808074951},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2028745412826538},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17329800128936768},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1450384557247162}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2326-6066.22544196.v1","doi":"https://doi.org/10.1158/2326-6066.22544196.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22544196.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Loss_of_LRRC33-Dependent_TGF_1_Activation_Enhances_Antitumor_Immunity_and_Checkpoint_Blockade_Therapy/22544196/1/files/40007616.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22544196","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_from_Loss_of_LRRC33-Dependent_TGF_1_Activation_Enhances_Antitumor_Immunity_and_Checkpoint_Blockade_Therapy/22544196","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.22544196.v1","doi":"https://doi.org/10.1158/2326-6066.22544196.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22544196.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_from_Loss_of_LRRC33-Dependent_TGF_1_Activation_Enhances_Antitumor_Immunity_and_Checkpoint_Blockade_Therapy/22544196/1/files/40007616.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362540698.pdf","grobid_xml":"https://content.openalex.org/works/W4362540698.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4212785863","https://openalex.org/W4362546945","https://openalex.org/W3014531772","https://openalex.org/W2792146488","https://openalex.org/W2602612283","https://openalex.org/W4392723007","https://openalex.org/W4362638654","https://openalex.org/W2906596920","https://openalex.org/W4362551172","https://openalex.org/W4362629614"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"from":[2],"Loss":[3],"of":[4],"LRRC33-Dependent":[5],"TGF\u03b21":[6],"Activation":[7],"Enhances":[8],"Antitumor":[9],"Immunity":[10],"and":[11],"Checkpoint":[12],"Blockade":[13],"Therapy":[14]},"counts_by_year":[],"updated_date":"2026-09-05T08:02:43.246662","created_date":"2023-04-06T00:00:00"}